MedPath

Transcutaneous Spinal Cord Stimulation (tSCS) in Therapy to Analyze Long-Term Effects on Spasticity and Gait Impairment in Multiple Sclerosis

Not Applicable
Recruiting
Conditions
Secondary Progressive Multiple Sclerosis (SPMS)Primary Progressive Multiple Sclerosis (PPMS)Gait impairmentSpasticity
G35.3
G35.2
Registration Number
DRKS00032742
Lead Sponsor
Charité Universitätsmedizin Berlin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
12
Inclusion Criteria

(1) Confirmed diagnosis of secondary or primary progressive multiple sclerosis;
(2) Symptoms: moderate to severe spasticity, gait symptoms;
(3) Tolerability of tSCS confirmed in previous study (immediate effect)

Exclusion Criteria

(1) Active lumbosacral nerve root compression;
(2) Time after surgery of the vertebral bodies in the stimulation area, as well as metal implants in the stimulation area (distance min. 5 cm from the edge of the adhesive electrode);
(3) Pacemaker implants;
(4) MS relapse event in the past 6 months;
(5) Current pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
(a) Change in spasticity measured by clinical assessment using modified Ashworth Scale (MAS).<br>(b) Change in gait speed expressed by a change in distance traveled in the 2-minute gait test.
Secondary Outcome Measures
NameTimeMethod
(c) Change in MS-specific clinical functional disability (EDSS Score),<br>(d) Change in maximum unaided walking distance,<br>(e) Change in individual gait parameters, such as step length, gait cycle, indicating improved/deteriorated gait function,<br>(f) Change in timed-up-and-go test (time reduced/increased),<br>(g) Altered postural stability,<br>(h) Correlation of spasticity score in clinical assessment (MAS, Tardieu scale) with electrophysiological parameters (tSCS double pulses, posterior root muscle reflexes)
© Copyright 2025. All Rights Reserved by MedPath